News
Gilead Sciences Inc. (NASDAQ:GILD) is one of the most undervalued quality stocks to buy according to hedge funds. On July 25, the European Medicines Agency’s Committee for Medicinal Products for Human ...
GAAP loss per share of $0.68 beat the analyst estimate by 50% in Q2 2025, and the GAAP net loss narrowed compared to the prior year. GAAP revenue of $2.7 million was slightly above expectations, ...
HO CHI MINH CITY / JAKARTA] Europe’s engagement with South-east Asia is ramping up, from the recent 150 million euro (S$224.5 ...
Teresa Ribera delivers Brussels’ harshest yet censure of the Jewish state. By Adi Nirman, Israel Hayom via JNS European ...
Laborate Pharmaceuticals has recently announced that its manufacturing site in Laborate Pharmaceuticals India Ltd, 111, ...
Launched by former Prime Minister Paetongtarn Shinawatra, suspended since July by the Constitutional Court, this nationwide ...
Panelists at the annual meeting of the American Bar Association emphasized that lawyers and bar associations play a key role ...
The spread of Lumpy skin disease, Bluetongue and African swine fever are keeping Swiss veterinary authorities on the alert.
Detailed price information for Cellectis S.A. ADR (CLLS-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results